Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
Science Translational Medicine · 06.11.2024 · 16 (772)
DOI: 10.1126/scitranslmed.adh9940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 06.11.2024. Verfasst von Jingjing Ding und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chon…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) has become a common health care burden worldwide. The high heterogeneity of NAFLD remains elusive and impairs outcomes of clinical diagnosis and pharmacotherapy. Several NAFLD classifications have been proposed on the basis of clinical, genetic, alcoholic, or serum metabolic analyses. Yet, accurately predicting the progression of NAFLD to cirrhosis or hepatocellular carcinoma (HCC) in patients remains a challenge. Here, on the basis of a Chinese cohort of patients, we classified NAFLD into three distinct molecular subtypes (NAFLD-mSI, NAFLD-mSII, and NAFLD-mSIII) using integrative multiomics including whole-genome sequencing (WGS), proteomics, phosphoproteomics, lipidomics, and metabolomics across a broad range of liver, blood, and urine specimens. We found that NAFLD-mSI had higher expression of CYP1A2 and CYP3A4, which alleviate hepatic steatosis through mediating free fatty acid/bile acid–mTOR–FXR/PPARα signaling. NAFLD-mSII displayed an elevated risk of liver cirrhosis along with increased hepatic infiltration of M1 and M2 macrophages because of lipid-triggered hepatic CCL2 and CRP production. NAFLD-mSIII exhibited a potential risk for HCC development by increased transcription of CEBPB- and ERCC3-regulated oncogenes because of activation of the EGF-EGFR/CHKA/PI3K-PDK1-AKT cascade. Next, we validated the existence of these three NAFLD molecular subtypes in an external cohort comprising 92 patients with NAFLD across three different Chinese hospitals. These findings may aid in understanding the molecular features underlying NAFLD heterogeneity, thereby facilitating clinical diagnosis and treatment strategies with the aim of preventing the development of liver cirrhosis and HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing 400038, China.
- Institute of Digestive Diseases of PLA, Third Military Medical University (Army Medical University), Chongqing 400038, China.
- Cholestatic Liver Diseases Center, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing 400038, China.
- Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Medical Research Center, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing 400038, Ch…
- Department of Emergency, the Third Xiangya Hospital, Central South University, Changsha 410013, China.
- Department of Infectious Diseases and Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang, China.
ORCID-Profile: Jingjing Ding, Huaizheng Liu, Xiaoxun Zhang, Nan Zhao, Ying Peng, Junping Shi, Jinjun Chen, Xiaoling Chi, Ling Li, Wen-Yue Liu, Chuanming Xie, Yi Li, Qiong Pan, Ying Xu, Shi-Ying Cai, Christopher D Byrne, Xinshou Ouyang, Liqun Zhang, Zhongyong Jiang, Ming-Hua Zheng, Fengjun Sun, Jin Chai
Förderung
- NIDDK NIH HHS
Zitieren
APA
Ding, J., Liu, H., Zhang, X., Zhao, N., Peng, Y., Shi, J., Chen, J., Chi, X., Li, L., Zhang, M., Liu, W. Y., Zhang, L., Ouyang, J., Yuan, Q., Liao, M., Tan, Y., Li, M., Xu, Z., Tang, W., …, & Chai, J. (2024). Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population. Science Translational Medicine, 16(772). https://doi.org/10.1126/scitranslmed.adh9940
Vancouver
Ding J, Liu H, Zhang X, Zhao N, Peng Y, Shi J, et al. Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population. Science Translational Medicine. 2024;16(772). doi:10.1126/scitranslmed.adh9940
BibTeX
@article{Ding2024,
author = {Ding, Jingjing and Liu, Huaizheng and Zhang, Xiaoxun and Zhao, Nan and Peng, Ying and Shi, Junping and Chen, Jinjun and Chi, Xiaoling and Li, Ling and Zhang, Mengni and Liu, Wen-Yue and Zhang, Liangjun and Ouyang, Jiafeng and Yuan, Qian and Liao, Min and Tan, Ya and Li, Mingqiao and Xu, Ziqian and Tang, Wan and Xie, Chuanming and Li, Yi and Pan, Qiong and Xu, Ying and Cai, Shi-Ying and Byrne, Christopher D and Targher, Giovanni and Ouyang, Xinshou and Zhang, Liqun and Jiang, Zhongyong and Zheng, Ming-Hua and Sun, Fengjun and Chai, Jin},
title = {Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population},
journal = {Science Translational Medicine},
year = {2024},
volume = {16},
number = {772},
doi = {10.1126/scitranslmed.adh9940}
}
EUVIMED